We are live on ! Find out more
PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

47 hedge funds and large institutions have $21.2M invested in Paratek Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

87% less call options, than puts

Call options by funds: $96K | Put options by funds: $712K

Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
47
Increased
–
Reduced
–
Closed
–
Calls
$96K
Puts
$712K
Net Calls
-$616K
Net Calls Change
-$616K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RAM
1
Roumell Asset Management
Maryland
$6.96M +$8.23M +192,104 New
NMC
2
NEA Management Company
Maryland
$6.3M +$7.45M +173,896 New
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$1.44M +$1.7M +39,678 New
Franklin Resources
4
Franklin Resources
California
$887K +$1.05M +24,475 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$792K +$937K +21,861 New
SM
6
Sabby Management
Florida
$610K +$721K +16,836 New
BI
7
BVF Inc
California
$453K +$536K +12,500 New
Northern Trust
8
Northern Trust
Illinois
$384K +$453K +10,580 New
BIT
9
BlackRock Institutional Trust
California
$286K +$338K +7,889 New
PAM
10
Panagora Asset Management
Massachusetts
$277K +$328K +7,650 New
Bank of America
11
Bank of America
North Carolina
$271K +$321K +7,486 New
Renaissance Technologies
12
Renaissance Technologies
New York
$248K +$293K +6,842 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$186K +$220K +5,131 New
TPM
14
T2 Partners Management
New York
$182K +$215K +5,008 New
PP
15
Paloma Partners
Connecticut
$165K +$196K +4,564 New
Deutsche Bank
16
Deutsche Bank
Germany
$153K +$183K +4,264 New
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$128K +$151K +3,532 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$120K +$141K +3,301 New
Millennium Management
19
Millennium Management
New York
$109K +$129K +3,000 New
BFA
20
BlackRock Fund Advisors
California
$109K +$129K +3,002 New
CI
21
Cowen Inc
New York
$100K +$118K +2,758 New
Morgan Stanley
22
Morgan Stanley
New York
$92K +$109K +2,543 New
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$88K +$105K +2,440 New
JP Morgan Chase
24
JP Morgan Chase
New York
$86K +$102K +2,371 New
Goldman Sachs
25
Goldman Sachs
New York
$80K +$94.2K +2,198 New
1
2

PRTK Hedge Fund Activity: Q2 2013 in Review

47 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q2 2013, worth a combined $21.2M.

Buyers outnumbered sellers: 47 funds opened new PRTK positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

  • 47 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $21.2M of Paratek Pharmaceuticals, Inc. stock for Q2 2013.
  • 47 funds opened new Paratek Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +47 holders.

Based on aggregated 13F filings for Q2 2013.